Back
Relay Therapeutics Vs. Celldex Therapeutics Industry Stock Comparison
Sell
31
RLAY
Relay Therapeutics
Last Price:
7.86
Seasonality Move:
-5.33%
Buy
58
CLDX
Celldex Therapeutics
Last Price:
41.15
Seasonality Move:
-0.32%
Sell
31
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy, Sell or Hold?
- The current Relay Therapeutics [RLAY] share price is $7.58. The Score for RLAY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RLAY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $41.85. The Score for CLDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- CLDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RLAY Stock Price Chart
What is Relay Therapeutics's stock price today?
-
The Relay Therapeutics share price today is $7.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLAY is experiencing slight selling pressure.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $41.85
The current trend is moderately bullish and CLDX is experiencing selling pressure, which indicates risk of future bearish movement.
RLAY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 51.35 | Buy |
| Chaikin Money Flow: | -606265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.45 - 8.01) | Buy |
| Bollinger Bands (100): | (6.39 - 8.03) | Buy |
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 56.29 | Buy |
| Chaikin Money Flow: | -545523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.85 - 43.05) | Buy |
| Bollinger Bands (100): | (34.5 - 40.9) | Buy |
RLAY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.1 | Sell |
| 20-day SMA: | 7.33 | Buy |
| 50-day SMA: | 7.6 | Sell |
| 200-day SMA: | 8.23 | Sell |
| 8-day EMA: | 7.68 | Sell |
| 20-day EMA: | 7.48 | Buy |
| 50-day EMA: | 7.39 | Buy |
| 200-day EMA: | 8.22 | Sell |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.23 | Sell |
| 20-day SMA: | 40.76 | Buy |
| 50-day SMA: | 38.36 | Buy |
| 200-day SMA: | 38.66 | Buy |
| 8-day EMA: | 42.1 | Sell |
| 20-day EMA: | 40.81 | Buy |
| 50-day EMA: | 39 | Buy |
| 200-day EMA: | 37.5 | Buy |
Relay Therapeutics Earnings Growth & RLAY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.03 per share, and a decrease next year of $0.24 per share.
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Relay Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celldex Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||